RxDoctor Payments Data

Kathleen Holthaus, OD

Optometrist · Omaha, NENPI 1215590898

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 36.0% of the total. Reporting peaked in 2019 at $1,453 and has fallen 86.7% since, to $194 in 2025. Among optometrist clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,693in general payments, 2019–2025

Across 57 payments — averaging $64.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Surgical Vision, Inc.$1K
  • Alcon$1K
  • Bausch & Lomb Americas Inc.$270
  • Johnson & Johnson Vision Care, Inc.$189
  • Sun Pharmaceutical Industries Inc.$172
  • Novartis$125
  • plus $496 from 9 others

What the payments were for

  • Travel & lodging$1,50041%
  • Food & beverage$2,19359%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,693 in reported general payments places this provider in the 90th percentile of 383 optometrist providers in Nebraska.

See all optometrist providers in Nebraska

Medicare billing

Part B allowed, 2024
$46,509
Medicare patients
299
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate25$482
Latanoprost41$401

Paid to pharmacies, not to this prescriber.

Other optometrist in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →